{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T21:24:32Z","timestamp":1783373072873,"version":"3.54.6"},"reference-count":114,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T00:00:00Z","timestamp":1588896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007311","name":"Deutsche Kinderkrebsstiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007311","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.00808","type":"journal-article","created":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T05:14:21Z","timestamp":1588914861000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":36,"title":["Cell Versus Cytokine \u2013 Directed Therapies for Hemophagocytic Lymphohistiocytosis (HLH) in Inborn Errors of Immunity"],"prefix":"10.3389","volume":"11","author":[{"given":"Oliver","family":"Wegehaupt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Wustrau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Lehmberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Ehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,5,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1136\/adc.27.136.519","article-title":"Familial haemophagocytic reticulosis.","volume":"27","author":"Farquhar","year":"1952","journal-title":"Arch Dis Child."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27344","article-title":"Is an infectious trigger always required for primary hemophagocytic lymphohistiocytosis? Lessons from in utero and neonatal disease.","volume":"65","author":"Heeg","year":"2018","journal-title":"Pediatr Blood Cancer."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00448","article-title":"Graded defects in cytotoxicity determine severity of hemophagocytic lymphohistiocytosis in humans and mice.","volume":"4","author":"Jessen","year":"2013","journal-title":"Front Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1182\/blood-2012-07-440339","article-title":"Distinct severity of HLH in both human and murine mutants with complete loss of cytotoxic effector PRF1, RAB27A, and STX11.","volume":"121","author":"Sepulveda","year":"2013","journal-title":"Blood."},{"key":"B5","doi-asserted-by":"publisher","first-page":"5794","DOI":"10.1182\/blood-2011-07-370148","article-title":"Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLH.","volume":"118","author":"Zhang","year":"2011","journal-title":"Blood."},{"key":"B6","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1651-2227.1991.tb11878.x","article-title":"Incidence in Sweden and clinical features of familial hemophagocytic Lymphohistiocytosis.","volume":"80","author":"Henter","year":"1991","journal-title":"Acta Paediatr Scand."},{"key":"B7","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1002\/pbc.25308","article-title":"Incidence and clinical presentation of primary hemophagocytic lymphohistiocytosis in Sweden.","volume":"62","author":"Meeths","year":"2015","journal-title":"Pediatr Blood Cancer."},{"key":"B8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.0105-2896.2010.00890.x","article-title":"Inherited defects in lymphocyte cytotoxic activity.","volume":"235","author":"Pachlopnik Schmid","year":"2010","journal-title":"Immunol Rev."},{"key":"B9","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/s0952-7915(00)00257-0","article-title":"The role of cytotoxicity in lymphocyte homeostasis.","volume":"13","author":"de Saint Basile","year":"2001","journal-title":"Curr Opin Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/nri1983","article-title":"Perforin-mediated target-cell death and immune homeostasis.","volume":"6","author":"Voskoboinik","year":"2006","journal-title":"Nat Rev Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/nri2803","article-title":"Molecular mechanisms of biogenesis and exocytosis of cytotoxic granules.","volume":"10","author":"de Saint Basile","year":"2010","journal-title":"Nat Rev Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"5184","DOI":"10.1182\/blood-2013-04-495309","article-title":"Perforin deficiency impairs a critical immunoregulatory loop involving murine CD8(+) T cells and dendritic cells.","volume":"121","author":"Terrell","year":"2013","journal-title":"Blood."},{"key":"B13","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s41577-018-0029-z","article-title":"IFNgamma: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy.","volume":"18","author":"Ivashkiv","year":"2018","journal-title":"Nat Rev Immunol."},{"key":"B14","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1182\/blood.V89.11.4100","article-title":"Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis.","volume":"89","author":"Osugi","year":"1997","journal-title":"Blood."},{"key":"B15","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1182\/blood.V78.11.2918.2918","article-title":"Hypercytokinemia in familial hemophagocytic lymphohistiocytosis.","volume":"78","author":"Henter","year":"1991","journal-title":"Blood."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1182\/blood-2004-08-2997","article-title":"macrophage activation syndrome: characteristic findings on liver biopsy illustrating the key role of activated, IFN-gamma-producing lymphocytes and IL-6- and TNF-Alpha-producing macrophages.","volume":"105","author":"Billiau","year":"2005","journal-title":"Blood."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00251","article-title":"Recognition and regulation of T cells by NK Cells.","volume":"7","author":"Pallmer","year":"2016","journal-title":"Front Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1182\/blood-2014-09-602946","article-title":"A novel immunoregulatory role for NK-cell cytotoxicity in protection from HLH-like immunopathology in mice.","volume":"125","author":"Sepulveda","year":"2015","journal-title":"Blood."},{"key":"B19","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1182\/blood-2003-10-3413","article-title":"An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder.","volume":"104","author":"Jordan","year":"2004","journal-title":"Blood."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1182\/blood-2010-07-298372","article-title":"Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome Type 1 (XLP-1\/SAP Deficiency) versus Type 2 (XLP-2\/XIAP deficiency).","volume":"117","author":"Pachlopnik Schmid","year":"2011","journal-title":"Blood."},{"key":"B21","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/26683","article-title":"The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM.","volume":"395","author":"Sayos","year":"1998","journal-title":"Nature."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.4049\/jimmunol.1701007","article-title":"SAP and lessons learned from a primary immunodeficiency.","volume":"199","author":"Cannons","year":"2017","journal-title":"J Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1084\/jem.192.3.337","article-title":"X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill epstein-barr virus-infected cells.","volume":"192","author":"Parolini","year":"2000","journal-title":"J Exp Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature05257","article-title":"XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome.","volume":"444","author":"Rigaud","year":"2006","journal-title":"Nature."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1016\/j.celrep.2014.05.008","article-title":"XIAP restricts TNF- and RIP3-dependent cell death and inflammasome activation.","volume":"7","author":"Yabal","year":"2014","journal-title":"Cell Rep."},{"key":"B26","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.clim.2013.07.004","article-title":"X-linked inhibitor of apoptosis (XIAP) deficiency: the spectrum of presenting manifestations beyond hemophagocytic lymphohistiocytosis.","volume":"149","author":"Speckmann","year":"2013","journal-title":"Clin Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.cyto.2013.09.007","article-title":"Sustained elevation of serum interleukin-18 and its association with hemophagocytic lymphohistiocytosis in XIAP deficiency.","volume":"65","author":"Wada","year":"2014","journal-title":"Cytokine."},{"key":"B28","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/imr.12616","article-title":"Interleukin-18: biological properties and role in disease pathogenesis.","volume":"281","author":"Kaplanski","year":"2018","journal-title":"Immunol Rev."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1182\/blood-2010-01-256099","article-title":"XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease.","volume":"116","author":"Marsh","year":"2010","journal-title":"Blood."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1038\/s41588-018-0251-4","article-title":"Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome.","volume":"50","author":"Gayden","year":"2018","journal-title":"Nat Genet."},{"key":"B31","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41577-019-0224-6","article-title":"TIM3 comes of age as an inhibitory receptor.","volume":"20","author":"Wolf","year":"2020","journal-title":"Nat Rev Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1038\/ng.3089","article-title":"An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome.","volume":"46","author":"Canna","year":"2014","journal-title":"Nat Genet."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/ng.3066","article-title":"Mutation of NLRC4 causes a syndrome of enterocolitis and autoinflammation.","volume":"46","author":"Romberg","year":"2014","journal-title":"Nat Genet."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1084\/jem.20190147","article-title":"A novel disorder involving dyshematopoiesis, inflammation, and HLH due to aberrant CDC42 function.","volume":"216","author":"Lam","year":"2019","journal-title":"J Exp Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"978","DOI":"10.3324\/haematol.2014.121608","article-title":"The syndrome of hemophagocytic lymphohistiocytosis in primary immunodeficiencies: implications for differential diagnosis and pathogenesis.","volume":"100","author":"Bode","year":"2015","journal-title":"Haematologica."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2017.00075","article-title":"Multifocal recurrent osteomyelitis and hemophagocytic lymphohistiocytosis in a boy with partial dominant IFN-GammaR1 deficiency: case report and review of the literature.","volume":"5","author":"Staines-Boone","year":"2017","journal-title":"Front Pediatr."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1182\/blood-2010-01-264218","article-title":"Inflammasome activation in NADPH oxidase defective mononuclear phagocytes from patients with chronic granulomatous disease.","volume":"116","author":"Meissner","year":"2010","journal-title":"Blood."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01676-0","article-title":"Wiskott-aldrich syndrome protein regulates autophagy and inflammasome activity in innate immune cells.","volume":"8","author":"Lee","year":"2017","journal-title":"Nat Commun."},{"key":"B39","doi-asserted-by":"publisher","first-page":"14384","DOI":"10.1073\/pnas.1613156113","article-title":"Familial mediterranean fever mutations lift the obligatory requirement for microtubules in pyrin inflammasome activation.","volume":"113","author":"Van Gorp","year":"2016","journal-title":"Proc Natl Acad Sci USA."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/srep29834","article-title":"F-actin dampens NLRP3 inflammasome activity via flightless-I and LRRFIP2.","volume":"6","author":"Burger","year":"2016","journal-title":"Sci Rep."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1182\/blood-2002-01-0172","article-title":"Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation.","volume":"100","author":"Henter","year":"2002","journal-title":"Blood."},{"key":"B42","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/bf00443367","article-title":"Familial hemophagocytic lymphohistiocytosis.","volume":"140","author":"Janka","year":"1983","journal-title":"Eur J Pediatr."},{"key":"B43","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1007\/s10875-017-0443-1","article-title":"Effective immunological guidance of genetic analyses including exome sequencing in patients evaluated for hemophagocytic lymphohistiocytosis.","volume":"37","author":"Ammann","year":"2017","journal-title":"J Clin Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.1182\/blood-2011-08-374199","article-title":"A prospective evaluation of degranulation assays in the rapid diagnosis of familial hemophagocytic syndromes.","volume":"119","author":"Bryceson","year":"2012","journal-title":"Blood."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1182\/blood-2016-12-753830","article-title":"Perforin and CD107a testing is superior to NK cell function testing for screening patients for genetic HLH.","volume":"129","author":"Rubin","year":"2017","journal-title":"Blood."},{"key":"B46","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/bjh.13462","article-title":"Malignancy-associated haemophagocytic lymphohistiocytosis in children and adolescents.","volume":"170","author":"Lehmberg","year":"2015","journal-title":"Br J Haematol."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27400","article-title":"Limitations of HLH-2004 criteria in distinguishing malignancy-associated hemophagocytic lymphohistiocytosis.","volume":"65","author":"Gurunathan","year":"2018","journal-title":"Pediatr Blood Cancer."},{"key":"B48","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jpeds.2014.03.047","article-title":"Hemophagocytic lymphohistiocytosis in imported pediatric visceral leishmaniasis in a nonendemic area.","volume":"165","author":"Bode","year":"2014","journal-title":"J Pediatr."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1016\/j.jaip.2018.05.031","article-title":"Recommendations for the use of etoposide-based therapy and bone marrow transplantation for the treatment of HLH: consensus statements by the HLH steering committee of the histiocyte society.","volume":"6","author":"Ehl","year":"2018","journal-title":"J Allergy Clin Immunol Pract."},{"key":"B50","doi-asserted-by":"publisher","first-page":"84","DOI":"10.4049\/jimmunol.1302282","article-title":"Etoposide selectively ablates activated T cells to control the immunoregulatory disorder hemophagocytic lymphohistiocytosis.","volume":"192","author":"Johnson","year":"2014","journal-title":"J Immunol."},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-017-0439-4","article-title":"How to treat involvement of the central nervous system in hemophagocytic lymphohistiocytosis?","volume":"19","author":"Horne","year":"2017","journal-title":"Curr Treat Options Neurol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1182\/blood-2017-06-788349","article-title":"Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study.","volume":"130","author":"Bergsten","year":"2017","journal-title":"Blood."},{"key":"B53","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1111\/ajt.12514","article-title":"A comprehensive and quantitative analysis of the major specificities in rabbit antithymocyte globulin preparations.","volume":"13","author":"Popow","year":"2013","journal-title":"Am J Transplant."},{"key":"B54","doi-asserted-by":"publisher","first-page":"e622","DOI":"10.1542\/peds.2006-3164","article-title":"Immunotherapy of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins: a single-center retrospective report of 38 patients.","volume":"120","author":"Mahlaoui","year":"2007","journal-title":"Pediatrics."},{"key":"B55","year":"2019","journal-title":"Hybrid Immunotherapy for Hemophagocytic LymphoHistiocytosis. Drug: ATG, Etoposide, Methotrexate, Hydrocortisone, Dexamethasone."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-124477","article-title":"Alemtuzumab as first line treatment in children with familial lymphohistiocytosis.","volume":"134","author":"Moshous","year":"2019","journal-title":"Blood."},{"key":"B57","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrclinonc.2010.40","article-title":"Alemtuzumab as a bridge to allogeneic SCT in atypical hemophagocytic lymphohistiocytosis.","volume":"7","author":"Strout","year":"2010","journal-title":"Nat Rev Clin Oncol."},{"key":"B58","year":"2019","journal-title":"Treatment of Familiar Lymphohistiocytosis (C-HLH), Drug: Alemtuzumab."},{"key":"B59","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/emmm.200900009","article-title":"Neutralization of IFNgamma defeats haemophagocytosis in LCMV-infected perforin- and Rab27a-deficient mice.","volume":"1","author":"Pachlopnik Schmid","year":"2009","journal-title":"EMBO Mol Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s40265-018-1046-8","article-title":"Emapalumab: first global approval.","volume":"79","author":"Al-Salama","year":"2019","journal-title":"Drugs."},{"key":"B61","year":"2019","journal-title":"Study to Assess the Efficacy and Safety of Emapalumab in Primary Haemophagocytic Lymphohistiocytosis, Drug: Emapalumab."},{"key":"B62","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1046\/j.1365-2249.2003.02237.x","article-title":"Increased serum levels of interferon-gamma-inducible protein 10 and monokine induced by gamma interferon in patients with haemophagocytic lymphohistiocytosis.","volume":"133","author":"Takada","year":"2003","journal-title":"Clin Exp Immunol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1182\/blood-2016-02-700013","article-title":"Therapeutic effect of JAK1\/2 blockade on the manifestations of hemophagocytic lymphohistiocytosis in mice.","volume":"128","author":"Maschalidi","year":"2016","journal-title":"Blood."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1182\/blood-2015-12-684399","article-title":"Janus kinase inhibition lessens inflammation and ameliorates disease in murine models of hemophagocytic lymphohistiocytosis.","volume":"127","author":"Das","year":"2016","journal-title":"Blood."},{"key":"B65","doi-asserted-by":"publisher","first-page":"E47","DOI":"10.1002\/ajh.24971","article-title":"Ruxolitinib as first-line treatment in secondary hemophagocytic lymphohistiocytosis: a single patient experience.","volume":"93","author":"Slostad","year":"2018","journal-title":"Am J Hematol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.hemonc.2017.07.002","article-title":"Ruxolitinib for secondary hemophagocytic lymphohistiocytosis: first case report.","volume":"12","author":"Sin","year":"2019","journal-title":"Hematol Oncol Stem Cell Ther."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1182\/bloodadvances.2017007526","article-title":"Ruxolitinib for treatment of refractory hemophagocytic lymphohistiocytosis.","volume":"1","author":"Broglie","year":"2017","journal-title":"Blood Adv."},{"key":"B68","year":"2020","journal-title":"Ruxolitinib Combined With Dexamethasone for HLH."},{"key":"B69","doi-asserted-by":"publisher","first-page":"e630","DOI":"10.1016\/S2352-3026(19)30156-5","article-title":"Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial.","volume":"6","author":"Ahmed","year":"2019","journal-title":"Lancet Haematol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1182\/blood-2017-12-820852","article-title":"Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome.","volume":"131","author":"Weiss","year":"2018","journal-title":"Blood."},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2012.00239","article-title":"Protection from inflammatory organ damage in a murine model of hemophagocytic lymphohistiocytosis using treatment with IL-18 binding protein.","volume":"3","author":"Chiossone","year":"2012","journal-title":"Front Immunol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrrheum.2015.179","article-title":"Macrophage activation syndrome in the era of biologic therapy.","volume":"12","author":"Grom","year":"2016","journal-title":"Nat Rev Rheumatol."},{"key":"B73","year":"2019","journal-title":"Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency."},{"key":"B74","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/cup.13466","article-title":"Refractory macrophage activation syndrome in the setting of adult\u2212onset still disease with hemophagocytic lymphohistiocytosis detected on skin biopsy treated with canakinumab and tacrolimus.","volume":"46","author":"Chamseddin","year":"2019","journal-title":"J Cutaneous Pathol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1080\/1744666X.2019.1629904","article-title":"Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome.","volume":"15","author":"Kotch","year":"2019","journal-title":"Expert Rev Clin Immunol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"3526","DOI":"10.1073\/pnas.1322831111","article-title":"IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans.","volume":"111","author":"de Luca","year":"2014","journal-title":"Proc Natl Acad Sci USA."},{"key":"B77","author":"Wustrau","year":"2019","journal-title":"Tocilizumab Strikingly Abates Inflammation in a Girl with Symptomatic Deficiency of the X-Linked Inhibitor of Apoptosis (XIAP) with Extremely Skewed X-Inactivation."},{"key":"B78","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1182\/blood-2004-07-2965","article-title":"Treatment of primary Epstein-Barr virus infection in patients with X-linked lymphoproliferative disease using B-cell-directed therapy.","volume":"105","author":"Milone","year":"2005","journal-title":"Blood."},{"key":"B79","doi-asserted-by":"publisher","first-page":"4041","DOI":"10.1182\/blood-2011-03-278127","article-title":"How i treat hemophagocytic lymphohistiocytosis.","volume":"118","author":"Jordan","year":"2011","journal-title":"Blood."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1182\/blood.v98.6.1882","article-title":"Differential cellular targets of Epstein-Barr virus. (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection.","volume":"98","author":"Kasahara","year":"2001","journal-title":"Blood."},{"key":"B81","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1097\/00043426-200210000-00011","article-title":"Adverse outcomes in primary hemophagocytic lymphohistiocytosis.","volume":"24","author":"Sung","year":"2002","journal-title":"J Pediatr Hematol Oncol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer."},{"key":"B83","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/j.1651-2227.2011.02501.x","article-title":"Risk factors for early death in children with haemophagocytic lymphohistiocytosis: outcome predictors in HLH.","volume":"101","author":"Trottestam","year":"2012","journal-title":"Acta Paediatr."},{"key":"B84","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/pbc.22774","article-title":"Rate of decline of ferritin in patients with hemophagocytic lymphohistiocytosis as a prognostic variable for mortality.","volume":"56","author":"Lin","year":"2011","journal-title":"Pediatr Blood Cancer."},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26308","article-title":"Salvage therapy for refractory hemophagocytic lymphohistiocytosis: a review of the published experience.","volume":"64","author":"Marsh","year":"2017","journal-title":"Pediatr Blood Cancer."},{"key":"B86","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/pbc.24188","article-title":"Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab.","volume":"60","author":"Marsh","year":"2013","journal-title":"Pediatr Blood Cancer."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1182\/blood.2019002289","article-title":"Emapalumab for the treatment of relapsed\/refractory hemophagocytic lymphohistiocytosis.","volume":"134","author":"Vallurupalli","year":"2019","journal-title":"Blood."},{"key":"B88","year":"2020","journal-title":"FDA Approves Emapalumab for Hemophagocytic Lymphohistiocytosis."},{"key":"B89","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1182\/bloodadvances.2018025858","article-title":"Treatment of refractory hemophagocytic lymphohistiocytosis with emapalumab despite severe concurrent infections.","volume":"3","author":"Lounder","year":"2019","journal-title":"Blood Adv."},{"key":"B90","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1182\/blood.V90.12.4743","article-title":"Treatment of familial hemophagocytic lymphohistiocytosis with bone marrow transplantation from HLA genetically nonidentical donors.","volume":"90","author":"Jabado","year":"1997","journal-title":"Blood."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1182\/blood.2019003811","article-title":"HAVCR2 mutations are associated with severe hemophagocytic syndrome in subcutaneous panniculitis-like T-Cell lymphoma.","volume":"135","author":"Sonigo","year":"2020","journal-title":"Blood."},{"key":"B92","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28302","article-title":"TIM-3 deficiency presenting with two clonally unrelated episodes of mesenteric and subcutaneous panniculitis-like t-cell lymphoma and hemophagocytic lymphohistiocytosis.","author":"Wegehaupt","year":"2020","journal-title":"Pediatr Blood Cancer."},{"key":"B93","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.immuni.2017.03.016","article-title":"NAIP-NLRC4 inflammasomes coordinate intestinal epithelial cell expulsion with eicosanoid and IL-18 release via activation of caspase-1 and -8.","volume":"46","author":"Rauch","year":"2017","journal-title":"Immunity."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1002\/pbc.25483","article-title":"Hemophagocytic lymphohistiocytosis in a female patient due to a heterozygous XIAP mutation and skewed X chromosome inactivation.","volume":"62","author":"Holle","year":"2015","journal-title":"Pediatr Blood Cancer."},{"key":"B95","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2174\/1566523214666140918112113","article-title":"Gene therapy for haemophagocytic lymphohistiocytosis.","volume":"14","author":"Booth","year":"2014","journal-title":"Curr Gene Ther."},{"key":"B96","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/mt.2014.242","article-title":"Perforin gene transfer into hematopoietic stem cells improves immune dysregulation in murine models of perforin deficiency.","volume":"23","author":"Carmo","year":"2015","journal-title":"Mol Ther."},{"key":"B97","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1089\/hum.2016.065","article-title":"High level of perforin expression is required for effective correction of hemophagocytic lymphohistiocytosis.","volume":"27","author":"Tiwari","year":"2016","journal-title":"Hum Gene Ther."},{"key":"B98","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1182\/bloodadvances.2017012088","article-title":"gene transfer into hematopoietic stem cells reduces HLH manifestations in a murine model of munc13-4 deficiency.","volume":"1","author":"Soheili","year":"2017","journal-title":"Blood Adv."},{"key":"B99","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1089\/hum.2019.025","article-title":"Retroviral UNC13D gene transfer restores cytotoxic activity of T cells derived from familial hemophagocytic lymphohistiocytosis Type 3 patients in vitro.","volume":"30","author":"Dettmer","year":"2019","journal-title":"Hum Gene Ther."},{"key":"B100","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1182\/blood-2012-07-445858","article-title":"SAP gene transfer restores cellular and humoral immune function in a murine model of X-linked lymphoproliferative disease.","volume":"121","author":"Rivat","year":"2013","journal-title":"Blood."},{"key":"B101","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1182\/blood.V89.3.794","article-title":"Frequency and severity of central nervous system lesions in hemophagocytic lymphohistiocytosis.","volume":"89","author":"Haddad","year":"1997","journal-title":"Blood."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1212\/WNL.0b013e31824f800a","article-title":"CNS involvement at the onset of primary hemophagocytic lymphohistiocytosis.","volume":"78","author":"Deiva","year":"2012","journal-title":"Neurology."},{"key":"B103","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1002\/pbc.22239","article-title":"Frequency and development of CNS involvement in chinese children with hemophagocytic lymphohistiocytosis.","volume":"54","author":"Yang","year":"2010","journal-title":"Pediatr Blood Cancer."},{"key":"B104","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/pbc.23405","article-title":"Neuroradiologic findings and follow-up with magnetic resonance imaging of the genetic forms of haemophagocytic lymphohistiocytosis with CNS involvement.","volume":"58","author":"Rego","year":"2012","journal-title":"Pediatr Blood Cancer."},{"key":"B105","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1182\/bloodadvances.2018027417","article-title":"Central nervous system\u2013restricted familial hemophagocytic lymphohistiocytosis responds to hematopoietic cell transplantation.","volume":"3","author":"Li","year":"2019","journal-title":"Blood Adv."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1093\/jnen\/nly094","article-title":"Histopathologic correlates of familial hemophagocytic lymphohistiocytosis isolated to the central nervous system.","volume":"77","author":"Solomon","year":"2018","journal-title":"J Neuropathol Exp Neurol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1182\/blood-2004-09-3590","article-title":"Severe and progressive encephalitis as a presenting manifestation of a novel missense perforin mutation and impaired cytolytic activity.","volume":"105","author":"Feldmann","year":"2005","journal-title":"Blood."},{"key":"B108","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1002\/pbc.21438","article-title":"A teenage boy with late onset hemophagocytic lymphohistiocytosis with predominant neurologic disease and perforin deficiency.","volume":"50","author":"Beaty","year":"2008","journal-title":"Pediatr Blood Cancer."},{"key":"B109","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s10072-010-0467-2","article-title":"Hemophagocytic lymphohistiocytosis with neurological presentation: MRI findings and a nearly miss diagnosis.","volume":"32","author":"Chiapparini","year":"2011","journal-title":"Neurol Sci."},{"key":"B110","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1212\/WNL.0000000000002729","article-title":"Progressive neurologic disorder: initial manifestation of hemophagocytic lymphohistiocytosis.","volume":"86","author":"Murphy","year":"2016","journal-title":"Neurology."},{"key":"B111","doi-asserted-by":"crossref","DOI":"10.1007\/s10875-020-00814-6","article-title":"Neuroinflammatory disease as an isolated manifestation of hemophagocytic lymphohistiocytosis.","author":"Blincoe","year":""},{"key":"B112","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.1182\/blood-2015-12-684498","article-title":"The minimum required level of donor chimerism in hereditary hemophagocytic lymphohistiocytosis.","volume":"127","author":"Hartz","year":"2016","journal-title":"Blood."},{"key":"B113","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.bbmt.2017.02.011","article-title":"Incidence and outcomes of central nervous system hemophagocytic lymphohistiocytosis relapse after reduced-intensity conditioning hematopoietic stem cell transplantation.","volume":"23","author":"Lounder","year":"2017","journal-title":"Biol Blood Marrow Transplant."},{"key":"B114","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1182\/blood-2018-01-827485","article-title":"Treatment dilemmas in asymptomatic children with primary hemophagocytic lymphohistiocytosis.","volume":"132","author":"Lucchini","year":"2018","journal-title":"Blood."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00808\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,13]],"date-time":"2021-03-13T09:37:56Z","timestamp":1615628276000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00808\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,8]]},"references-count":114,"alternative-id":["10.3389\/fimmu.2020.00808"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.00808","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,8]]},"article-number":"808"}}